Bellevue Life Sciences Acquisition
BLAC3.0100.00% ( 0.000 )
Q3 FY2024 Earnings
Financial report interval: 2024.06.30 - 2024.09.30
Overview: Bellevue Life Sciences Acquisition(BLAC) the EBIT is -454.13 K (-10.65%);the EPS is -0.06 (-794.9%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B10.65%
----
----
EPS
-0.06794.92%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf